Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes

Nature Communications, Published online: 22 August 2026; doi:10.1038/s41467-026-77068-0 A large international study found that certain diabetes drugs (GLP-1 receptor agonists) may link to a lower risk of tuberculosis than other common treatments. These medications may offer added protection against tuberculosis in type 2 diabetes. The post Glucagon-like Peptide-1 Receptor Agonists and Risk of…